Insmed | INSM - Costo Del Venduto





Costo Del Venduto Cambiamento Data
BioMarin Pharmaceutical USD 276.29M 76.8M 2026-06
Cytokinetics USD 5.59M 5.43M 2026-06
Gilead Sciences USD 1000M 445M 2026-06
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 69.29M 19.79M 2026-06
Novartis USD 3.46B 83M 2026-03
Regeneron Pharmaceuticals USD 576.5M 92.9M 2026-06
Sarepta Therapeutics USD 150.1M 40.64M 2026-06
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Vertex Pharmaceuticals USD 489.2M 96.4M 2026-06